Radiculitis and its Current Approach
Dr.Avinash Shankar1* , Dr.Amresh Shankar2 , Dr Anuradha Shankar3
Citation : Avinash Shankar, Dr.Amresh Shankar, Dr Anuradha Shankar, Radiculitis and its Current Approach International Journal of Clinical Chemistry and Laboratory Medicine 2019, 5(2) : 25-34 .
Radiculitis, an agonizing painful condition is due to inflammation of the spinal nerve root or roots in the region of neural foramen and its presentation is termed as Radiculopathy which commonly affect the cervical and lumbar region.
Incidence of lumbar radiculopathy is 5% to more than 30% with a lifetime prevalence of 60% to 90% and cervical radiculopathy is107.3 per 100,000 for men and 63.5 per 100,000 for women with a peak at 50 to 54 years of age.
Inspite of advancement in diagnostics i.e- CT scan and MRI and treatment with traction,surgical decompression and other adjuvant like neuro vitamin supplementation and analgesic antiarthritic supplementation satisfactory clinical response with improved quality of life reamain a challenge ,thus a therapeutic regime combined with herbal neurotonic and neuro vigorative been evaluated in patients who failed to respond the present therapeutics.
Objective of study
To assess the herbal neurogenic containing therapeutic regime ensuring clinical relief and improving quality of life in patients of radiculopathy.
Material & Method
718 diagnosed and already treated cases of radiculopathy attending at Centre for Critical Care, National Institute of Health & Research Warisaliganj (Nawada)Bihar been selected, interrogated, examined clinically, assessed and analysed their previous investigation reports, therapeutics taken and their effect. Irrespective of their clinical severity all patients were advocated the prescribed regime and were followed for post therapy 2 years for which patients been given a follow up card to record the changes.
Result
Patients of mild, moderate and severe grade of clinical presentation shows grade I clinical response with improved quality of life in 100%,80.2% and 88.4% patients respectively, though 0.9% and 1.9% of moderate and severe grade of clinical severity fails to prove worth.
No patients of either status had alteration in bio parameters or any adversity during therapy or 2 years of post-therapy follow up .